HOXA13 and central nervous system cancer: In four glioma cell lines, migration and invasion was inhibited by the introduction of a specific lentivirus containing a HOXA13 siRNA, and the β-catenin proteins levels in the nucleus were decreased after treatment with Lenti-si HOXA13.